SG
MRNA icon

Stonnington Group’s Moderna MRNA Stock Holding History

Stonnington Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,340
Closed -$231K – 215
2022
Q2 		$231K Buy
+1,340
New +$192K 0.06% 199
2022
Q1 		– Sell
-1,800
Closed -$399K – 260
2021
Q4 		$399K Sell
1,800
-475
-21% -$139K 0.09% 184
2021
Q3 		$694K Sell
2,275
-155
-6% -$57.2K 0.16% 138
2021
Q2 		$566K Hold
2,430
– – 0.13% 160
2021
Q1 		$371K Buy
+2,430
New +$352K 0.09% 188

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stonnington Group's MRNA Position: Q3 2022 in Review

Stonnington Group sold out of Moderna (MRNA) in Q3 2022, closing a stake of 1,340 shares — an estimated $231K sold.

Stonnington Group first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $694K in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Stonnington Group reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Stonnington Group sold 1,340 Moderna shares in Q3 2022, an estimated $231K.
  • Stonnington Group first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
  • Stonnington Group's Moderna position peaked at $694K in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Stonnington Group's 13F filing for Q3 2022, filed 20 Oct 2022.